Introduction: the role of the thiazolidinediones in the cardiovascular risk management of type 2 diabetes

Author： Barnett A.H.  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.21, Iss.3, 2005-03, pp. : 1-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Type 2 diabetes, thiazolidinediones, and cardiovascular risk

By Taylor Clare   Hobbs FD Richard  

British Journal of General Practice, Vol. 59, Iss. 564, 2009-07 ,pp. : 520-524

Royal College of General Practitioners

Access to resources Recommend Favorite

Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone

By  

Current Drug Safety, Vol. 5, Iss. 3, 2010-07 ,pp. : 234-244

Bentham Science Publishers

Access to resources Recommend Favorite

Electronic messaging intervention for management of cardiovascular risk factors in type 2 diabetes mellitus: A randomised controlled trial

By  

JOURNAL OF CLINICAL NURSING, Vol. 27, Iss. 3-4, 2018-02 ,pp. : 612-620

John Wiley & Sons Inc

Access to resources Recommend Favorite

Control of glycemia and other cardiovascular disease risk factors in older adults with type 2 diabetes mellitus: Data from the Adult Diabetes Control and Management

By  

GERIATRICS & GERONTOLOGY INTERNATIONAL, Vol. 14, Iss. 1, 2014-01 ,pp. : 130-137

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cardiovascular risk factors and their management in 1282 adult people with type 1 diabetes

By Syed Ateeq   Hussain Sania   Nightingale Peter   De Parijat   Charlton Mary H.   Gangopadhyay Kalyan   Barnett Anthony H.   Narendran Parth  

Current Medical Research and Opinion, Vol. 23, Iss. 12, 2007-12 ,pp. : 2921-2927

Informa Healthcare

Access to resources Recommend Favorite